日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies

BeSt 和 IMPROVED 研究中接受达标治疗的早期类风湿性关节炎患者的长期临床结果

Heckert, Sascha Louise; Maassen, Johanna M; Nevins, Isabell; Baudoin, Paul; Steup-Beekman, Gerda M; Huizinga, Tom W J; Bergstra, Sytske Anne; Allaart, Cornelia F

Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort

接受达标治疗的类风湿关节炎和不稳定型心绞痛患者的长期死亡率:BeSt 和 IMPROVED 队列研究结果

Heckert, Sascha Louise; Maassen, Johanna Maria; le Cessie, S; Goekoop-Ruiterman, Y P M; Güler-Yüksel, Melek; Lems, Willem; Huizinga, Tom Wj; Bergstra, Sytske Anne; Allaart, Cornelia F

Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study

贝利木单抗皮下注射联合一个疗程利妥昔单抗序贯治疗系统性红斑狼疮患者的疗效和安全性:一项3期随机、安慰剂对照的BLISS-BELIEVE研究

Aranow, Cynthia; Allaart, Cornelia F; Amoura, Zahir; Bruce, Ian N; Cagnoli, Patricia C; Chatham, Walter W; Clark, Kenneth L; Furie, Richard; Groark, James; Urowitz, Murray B; van Vollenhoven, Ronald; Daniels, Mark; Fox, Norma Lynn; Gregan, Yun Irene; Henderson, Robert B; van Maurik, André; Ocran-Appiah, Josephine C; Oldham, Mary; Roth, David A; Shanahan, Don; Tak, Paul P; Teng, Yk Onno

Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study

泼尼松的使用、疾病活动度以及早期类风湿关节炎患者高血糖和糖尿病的发生:BeSt 研究的 10 年亚组分析

van der Pol, Joy Ardjuna; Allaart, Cornelia F; Lems, Willem; van der Kooij, Sjoerd M; Huizinga, Tom W J; Bergstra, Sytske Anne

Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study

预后不良因素是否是类风湿性关节炎患者治疗决策的现实依据?来自 IMPROVED 研究的启示

van der Pol, Joy Ardjuna; Allaart, Cornelia F; Huizinga, Tom W J; Bergstra, Sytske Anne

Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial

在以达标治疗为导向的幼年特发性关节炎治疗中,增加依那西普剂量是否有助于达到治疗目标?一项对BeSt for Kids随机临床试验的事后分析

van Dijk, Bastiaan T; Bergstra, Sytske Anne; van den Berg, J Merlijn; Schonenberg-Meinema, Dieneke; van Suijlekom-Smit, Lisette W A; van Rossum, Marion A J; Koopman-Keemink, Yvonne; Ten Cate, Rebecca; Allaart, Cornelia F; Brinkman, Daniëlle M C; Hissink Muller, Petra C E

Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis

针对类风湿性关节炎患者,在开始使用糖皮质激素作为桥接治疗后继续使用糖皮质激素的个体患者数据荟萃分析

van Ouwerkerk, Lotte; Boers, Maarten; Emery, Paul; de Jong, Pascal Hp; Landewé, Robert Bm; Lems, Willem; Smolen, Josef S; Verschueren, Patrick; Huizinga, Tom Wj; Allaart, Cornelia F; Bergstra, Sytske Anne

Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment

尽管接受了长期靶向治疗,类风湿性关节炎患者的关节炎症发生频率仍与局部关节损伤进展相关。

Heckert, Sascha L; Bergstra, Sytske Anne; Goekoop-Ruiterman, Yvonne P M; Güler-Yüksel, Melek; Lems, Willem F; Matthijssen, Xanthe M E; van Oosterhout, Maikel; Huizinga, Tom W J; Allaart, Cornelia F

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

从疑似系统性硬化症到确诊系统性硬化症的进展以及抗拓扑异构酶I抗体的作用

Liem, Sophie I E; Neppelenbroek, Sam; Fehres, Cynthia M; Wevers, Brigitte A; Toes, René E M; Allaart, Cornelia F; Huizinga, Tom W J; Scherer, Hans Ulrich; De Vries-Bouwstra, Jeska K

Patterns of clinical joint inflammation in juvenile idiopathic arthritis

幼年特发性关节炎的临床关节炎症模式

Heckert, Sascha L; Hissink-Muller, Petra C E; van den Berg, J Merlijn; Schonenberg-Meinema, Dieneke; van Suijlekom-Smit, Lisette W A; van Rossum, Marion A J; Koopman, Yvonne; Ten Cate, Rebecca; Brinkman, Danielle M C; Huizinga, Tom W J; Allaart, Cornelia F; Bergstra, Sytske Anne